NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
NKGN on OTC
Shares outstanding
133,846,019
Price per share
$0.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,755,935
Total reported value
$303,153
% of total 13F portfolios
0%
Share change
+2,755,935
Value change
+$303,153
Number of holders
1
Price from insider filings
$0.06
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Song Paul Y. 54% $11,472,848 63,738,042 Paul Y. Song 05 May 2025
CFIC-2015 NV Family Investments, LLC 47% $18,320,843 63,175,321 CFIC-2015 NV Family Investments, LLC 27 May 2025
PATHSTONE FAMILY OFFICE, LLC 7.9% $503,579 2,797,661 PATHSTONE FAMILY OFFICE, LLC 17 Oct 2024
METEORA CAPITAL, LLC 6.1% -21% $496,068 -$2,918 2,755,935 -0.58% Meteora Capital, LLC 31 Mar 2025

As of 30 Sep 2025, 1 institutional investors reported holding 2,755,935 shares of NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN). This represents 2.1% of the company’s total 133,846,019 outstanding shares.

Institutional Holders of NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 2,755,935 $303,153 +$303,153 $0.11 1
2025 Q2 0 $0 -$160,764 $0.06 0
2025 Q1 892,354 $160,764 -$4,302,179 $0.18 3
2024 Q4 7,585,892 $4,970,520 +$3,317,930 $0.66 23
2024 Q3 2,571,782 $971,234 +$77,753 $0.38 18
2024 Q2 3,416,873 $4,243,467 +$494,454 $1.27 17
2024 Q1 3,018,878 $5,664,743 -$5,173,115 $1.89 13
2023 Q4 3,749,952 $13,675,057 +$13,675,057 $2.75 9